Ovid Therapeutics GAAP EPS of -$0.17 beats by $0.04
Nov. 08, 2022 8:57 AM ETOvid Therapeutics Inc. (OVID)By: Niloofer Shaikh, SA News Editor
- Ovid Therapeutics press release (NASDAQ:OVID): Q3 GAAP EPS of -$0.17 beats by $0.04.
- Revenue of $11.1K.
- The company ended Q3 with cash, cash equivalents and marketable securities of $137.9M, which is expected to support the advancement of Ovid's epilepsy pipeline into 2025